<p>Fresenius Medical Care AG  Co. KGaA（紐約證券交易所代碼：FMS - 獲取免費報告）的股票在目前覆蓋該公司的九位分析師中被評定為 “減持”，Marketbeat.com 報道。四位投資分析師對該股票給予了賣出建議，五位則對該公司給予了持有建議。在過去一年中，發佈報告的券商對該股票的平均十二個月目標價為 28.00 美元。</p>
<ul>
<li>醫院股票 - 最值得購買的醫院股票</li>
</ul>
<p>最近，一些分析師對該股票發表了評論。華爾街禪在 5 月 9 日的研究報告中將 Fresenius Medical Care AG  Co. KGaA 的股票評級從 “買入” 下調至 “持有”。Erste Group Bank 在 2 月 5 日的研究報告中將 Fresenius Medical Care AG  Co. KGaA 的股票評級從 “強力買入” 下調至 “持有”。Weiss Ratings 在 5 月 7 日的研究報告中將 Fresenius Medical Care AG  Co. KGaA 的股票評級從 “持有（c+）” 下調至 “持有（c）”。花旗集團在 4 月 24 日的研究報告中重申了 Fresenius Medical Care AG  Co. KGaA 的 “中性” 評級。最後，傑富瑞金融集團在 5 月 8 日的研究報告中將 Fresenius Medical Care AG  Co. KGaA 的股票評級從 “強烈賣出” 上調至 “適度賣出”。</p>
<p><strong>閲讀我們關於 FMS 的最新報告</strong></p>
<h2>Fresenius Medical Care AG  Co. KGaA 的機構交易</h2>
<ul>
<li>最佳醫療股票 - 現在值得購買的醫療股票</li>
</ul>
<p>一些機構投資者和對沖基金最近調整了對該股票的持有。EverSource Wealth Advisors LLC 在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 50.3%。EverSource Wealth Advisors LLC 現在擁有 4,135 股該公司的股票，價值 93,000 美元，此前在上一季度購買了 1,383 股。加拿大皇家銀行在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 479.2%。加拿大皇家銀行現在擁有 216,861 股該公司的股票，價值 4,893,000 美元，此前在上一季度購買了 179,418 股。Quantinno Capital Management LP 在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 15.7%。Quantinno Capital Management LP 現在擁有 341,343 股該公司的股票，價值 7,701,000 美元，此前在上一季度購買了 46,428 股。Sei Investments Co.在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 80.7%。Sei Investments Co.現在擁有 120,704 股該公司的股票，價值 2,723,000 美元，此前在上一季度購買了 53,922 股。最後，Cetera Investment Advisers 在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 76.7%。Cetera Investment Advisers 現在擁有 15,917 股該公司的股票，價值 359,000 美元，此前在上一季度購買了 6,909 股。對沖基金和其他機構投資者持有該公司 8.37% 的股份。</p>
<h2>Fresenius Medical Care AG  Co. KGaA 股價上漲 1.4%</h2>
<p>Fresenius Medical Care AG  Co. KGaA 的股票在週五開盤價為 22.51 美元。該公司的 50 日簡單移動平均線為 22.44 美元，200 日簡單移動平均線為 23.08 美元。該公司的市值為 125.7 億美元，市盈率為 11.85，市盈率增長比率為 4.01，貝塔值為 0.81。Fresenius Medical Care AG  Co. KGaA 的 52 周低點為 20.02 美元，52 周高點為 29.71 美元。該公司的債務與股本比率為 0.40，速動比率為 0.86，流動比率為 1.20。</p>
<p>Fresenius Medical Care AG  Co. KGaA（紐約證券交易所代碼：FMS - 獲取免費報告）最近在 3 月 31 日發佈了季度財報。該公司報告本季度每股收益為 1.05 美元。該季度的營業收入為 53.4 億美元。Fresenius Medical Care AG  Co. KGaA 的淨利潤率為 4.88%，股本回報率為 8.90%。作為一個整體，股票分析師預測 Fresenius Medical Care AG  Co. KGaA 在當前財政年度將發佈 2.24 美元的每股收益。</p>
<h2>Fresenius Medical Care AG  Co. KGaA 增加股息</h2>
<p>該公司最近還宣佈了一項年度股息，將於 6 月 8 日支付。5 月 22 日的股東將獲得每股 0.8716 美元的股息。這比 Fresenius Medical Care AG  Co. KGaA 之前的年度股息 0.79 美元有所增加。這代表了 387.0% 的股息收益率。該股息的除息日期為 5 月 22 日。Fresenius Medical Care AG  Co. KGaA 目前的股息支付比率為 30.00%。</p>
<h2>Fresenius Medical Care AG  Co. KGaA 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Fresenius Medical Care AG  Co KGaA 是全球最大的腎臟疾病產品和服務的綜合供應商。該公司的主要業務活動包括運營透析診所以及製造和分銷透析設備、透析機、透析器、耗材和相關療法。通過其全球診所網絡，Fresenius Medical Care 提供全面的腎臟護理，包括血液透析和腹膜透析治療、患者教育和支持服務。</p>
<p>在其產品部門，該公司設計和生產透析機、水處理系統以及高通量透析器和血管通路等一次性產品。</p>
<h2>另請參閲</h2>
<ul>
<li>我們更看好的五隻股票，超過 Fresenius Medical Care AG  Co. KGaA</li>
<li>Meta Platforms 裁員 10% 引發關於人工智能支出的更大問題</li>
<li>隨着小型股表現持續，這兩隻 ETF 提供了投資機會</li>
<li>硅谷動盪：人工智能交易超越 NVIDIA</li>
<li>上週 Hims  Hers 財報失利的銀 lining</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UWU3ltYm9sPUZNUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UWU3ltYm9sPUZNUw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Fresenius Medical Care AG &amp; Co. KGaA 嗎？</h2>
<p>在考慮 Fresenius Medical Care AG &amp; Co. KGaA 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Fresenius Medical Care AG &amp; Co. KGaA 並不在名單上。</p>
<p>儘管 Fresenius Medical Care AG &amp; Co. KGaA 目前在分析師中被評為減持評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Fresenius Medical Care AG & Co. KGaA（紐約證券交易所代碼：FMS）獲得了九位分析師的共識評級為 “減持”，其中四位建議賣出，五位建議持有。平均目標價為 28.00 美元。最近的評級變動包括來自 Wall Street Zen 和 Erste Group Bank 的下調。該股票開盤價為 22.51 美元，市值為 125.7 億美元。公司報告了上一季度每股收益為 1.05 美元，並宣佈年度股息為 0.8716 美元</p>

<p>Shares of Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - Get Free Report) have been assigned an average rating of &#34;Reduce&#34; from the nine analysts that are currently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a sell recommendation and five have issued a hold recommendation on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $28.00.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG  Co. KGaA（紐約證券交易所代碼：FMS - 獲取免費報告）的股票在目前覆蓋該公司的九位分析師中被評定為 “減持”，Marketbeat.com 報道。四位投資分析師對該股票給予了賣出建議，五位則對該公司給予了持有建議。在過去一年中，發佈報告的券商對該股票的平均十二個月目標價為 28.00 美元。</p>
</div><ul>
<li>Hospital Stocks - Best Hospital Stocks to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>醫院股票 - 最值得購買的醫院股票</li>
</ul>
</div><p>A number of analysts have recently commented on the stock. Wall Street Zen cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, May 9th. Erste Group Bank cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, February 5th. Weiss Ratings cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;hold (c+)&#34; rating to a &#34;hold (c)&#34; rating in a research note on Thursday, May 7th. Citigroup reissued a &#34;neutral&#34; rating on shares of Fresenius Medical Care AG &amp; Co. KGaA in a research note on Friday, April 24th. Finally, Jefferies Financial Group raised shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;strong sell&#34; rating to a &#34;moderate sell&#34; rating in a research note on Friday, May 8th.</p>
<div class="lb-trans"><p>最近，一些分析師對該股票發表了評論。華爾街禪在 5 月 9 日的研究報告中將 Fresenius Medical Care AG  Co. KGaA 的股票評級從 “買入” 下調至 “持有”。Erste Group Bank 在 2 月 5 日的研究報告中將 Fresenius Medical Care AG  Co. KGaA 的股票評級從 “強力買入” 下調至 “持有”。Weiss Ratings 在 5 月 7 日的研究報告中將 Fresenius Medical Care AG  Co. KGaA 的股票評級從 “持有（c+）” 下調至 “持有（c）”。花旗集團在 4 月 24 日的研究報告中重申了 Fresenius Medical Care AG  Co. KGaA 的 “中性” 評級。最後，傑富瑞金融集團在 5 月 8 日的研究報告中將 Fresenius Medical Care AG  Co. KGaA 的股票評級從 “強烈賣出” 上調至 “適度賣出”。</p>
</div><p><strong>Read Our Latest Report on FMS</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 FMS 的最新報告</strong></p>
</div><h2>Institutional Trading of Fresenius Medical Care AG &amp; Co. KGaA</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG  Co. KGaA 的機構交易</h2>
</div><ul>
<li>Best Healthcare Stocks - Healthcare Stocks to Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>最佳醫療股票 - 現在值得購買的醫療股票</li>
</ul>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC increased its stake in shares of Fresenius Medical Care AG &amp; Co. KGaA by 50.3% during the first quarter. EverSource Wealth Advisors LLC now owns 4,135 shares of the company's stock worth $93,000 after purchasing an additional 1,383 shares in the last quarter. Royal Bank of Canada increased its stake in shares of Fresenius Medical Care AG &amp; Co. KGaA by 479.2% during the first quarter. Royal Bank of Canada now owns 216,861 shares of the company's stock worth $4,893,000 after purchasing an additional 179,418 shares in the last quarter. Quantinno Capital Management LP increased its stake in shares of Fresenius Medical Care AG &amp; Co. KGaA by 15.7% during the first quarter. Quantinno Capital Management LP now owns 341,343 shares of the company's stock worth $7,701,000 after purchasing an additional 46,428 shares in the last quarter. Sei Investments Co. increased its stake in shares of Fresenius Medical Care AG &amp; Co. KGaA by 80.7% during the first quarter. Sei Investments Co. now owns 120,704 shares of the company's stock worth $2,723,000 after purchasing an additional 53,922 shares in the last quarter. Finally, Cetera Investment Advisers grew its stake in Fresenius Medical Care AG &amp; Co. KGaA by 76.7% during the 1st quarter. Cetera Investment Advisers now owns 15,917 shares of the company's stock valued at $359,000 after acquiring an additional 6,909 shares in the last quarter. Hedge funds and other institutional investors own 8.37% of the company's stock.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近調整了對該股票的持有。EverSource Wealth Advisors LLC 在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 50.3%。EverSource Wealth Advisors LLC 現在擁有 4,135 股該公司的股票，價值 93,000 美元，此前在上一季度購買了 1,383 股。加拿大皇家銀行在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 479.2%。加拿大皇家銀行現在擁有 216,861 股該公司的股票，價值 4,893,000 美元，此前在上一季度購買了 179,418 股。Quantinno Capital Management LP 在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 15.7%。Quantinno Capital Management LP 現在擁有 341,343 股該公司的股票，價值 7,701,000 美元，此前在上一季度購買了 46,428 股。Sei Investments Co.在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 80.7%。Sei Investments Co.現在擁有 120,704 股該公司的股票，價值 2,723,000 美元，此前在上一季度購買了 53,922 股。最後，Cetera Investment Advisers 在第一季度將其在 Fresenius Medical Care AG  Co. KGaA 的股份增加了 76.7%。Cetera Investment Advisers 現在擁有 15,917 股該公司的股票，價值 359,000 美元，此前在上一季度購買了 6,909 股。對沖基金和其他機構投資者持有該公司 8.37% 的股份。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Trading Up 1.4%</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG  Co. KGaA 股價上漲 1.4%</h2>
</div><p>Shares of Fresenius Medical Care AG &amp; Co. KGaA stock opened at $22.51 on Friday. The firm has a 50-day simple moving average of $22.44 and a two-hundred day simple moving average of $23.08. The company has a market cap of $12.57 billion, a P/E ratio of 11.85, a price-to-earnings-growth ratio of 4.01 and a beta of 0.81. Fresenius Medical Care AG &amp; Co. KGaA has a fifty-two week low of $20.02 and a fifty-two week high of $29.71. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.86 and a current ratio of 1.20.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG  Co. KGaA 的股票在週五開盤價為 22.51 美元。該公司的 50 日簡單移動平均線為 22.44 美元，200 日簡單移動平均線為 23.08 美元。該公司的市值為 125.7 億美元，市盈率為 11.85，市盈率增長比率為 4.01，貝塔值為 0.81。Fresenius Medical Care AG  Co. KGaA 的 52 周低點為 20.02 美元，52 周高點為 29.71 美元。該公司的債務與股本比率為 0.40，速動比率為 0.86，流動比率為 1.20。</p>
</div><p>Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - Get Free Report) last issued its quarterly earnings data on Tuesday, March 31st. The company reported $1.05 earnings per share for the quarter. The business had revenue of $5.34 billion during the quarter. Fresenius Medical Care AG &amp; Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. As a group, equities analysts predict that Fresenius Medical Care AG &amp; Co. KGaA will post 2.24 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG  Co. KGaA（紐約證券交易所代碼：FMS - 獲取免費報告）最近在 3 月 31 日發佈了季度財報。該公司報告本季度每股收益為 1.05 美元。該季度的營業收入為 53.4 億美元。Fresenius Medical Care AG  Co. KGaA 的淨利潤率為 4.88%，股本回報率為 8.90%。作為一個整體，股票分析師預測 Fresenius Medical Care AG  Co. KGaA 在當前財政年度將發佈 2.24 美元的每股收益。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Increases Dividend</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG  Co. KGaA 增加股息</h2>
</div><p>The business also recently announced an annual dividend, which will be paid on Monday, June 8th. Stockholders of record on Friday, May 22nd will be paid a dividend of $0.8716 per share. This is an increase from Fresenius Medical Care AG &amp; Co. KGaA's previous annual dividend of $0.79. This represents a dividend yield of 387.0%. The ex-dividend date of this dividend is Friday, May 22nd. Fresenius Medical Care AG &amp; Co. KGaA's dividend payout ratio is presently 30.00%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項年度股息，將於 6 月 8 日支付。5 月 22 日的股東將獲得每股 0.8716 美元的股息。這比 Fresenius Medical Care AG  Co. KGaA 之前的年度股息 0.79 美元有所增加。這代表了 387.0% 的股息收益率。該股息的除息日期為 5 月 22 日。Fresenius Medical Care AG  Co. KGaA 目前的股息支付比率為 30.00%。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Company Profile</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG  Co. KGaA 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Fresenius Medical Care AG &amp; Co KGaA is the world's largest integrated provider of products and services for individuals with renal diseases. The company's primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG  Co KGaA 是全球最大的腎臟疾病產品和服務的綜合供應商。該公司的主要業務活動包括運營透析診所以及製造和分銷透析設備、透析機、透析器、耗材和相關療法。通過其全球診所網絡，Fresenius Medical Care 提供全面的腎臟護理，包括血液透析和腹膜透析治療、患者教育和支持服務。</p>
</div><p>In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.</p>
<div class="lb-trans"><p>在其產品部門，該公司設計和生產透析機、水處理系統以及高通量透析器和血管通路等一次性產品。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另請參閲</h2>
</div><ul>
<li>Five stocks we like better than Fresenius Medical Care AG &amp; Co. KGaA</li>
<li>Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending</li>
<li>As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure</li>
<li>Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA</li>
<li>The Silver Lining of Last Week's Hims &amp; Hers Earnings Miss</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，超過 Fresenius Medical Care AG  Co. KGaA</li>
<li>Meta Platforms 裁員 10% 引發關於人工智能支出的更大問題</li>
<li>隨着小型股表現持續，這兩隻 ETF 提供了投資機會</li>
<li>硅谷動盪：人工智能交易超越 NVIDIA</li>
<li>上週 Hims  Hers 財報失利的銀 lining</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZNUw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=FMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Fresenius Medical Care AG &amp; Co. KGaA Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Fresenius Medical Care AG &amp; Co. KGaA 嗎？</h2>
</div><p>Before you consider Fresenius Medical Care AG &amp; Co. KGaA, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Fresenius Medical Care AG &amp; Co. KGaA 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care AG &amp; Co. KGaA wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Fresenius Medical Care AG &amp; Co. KGaA 並不在名單上。</p>
</div><p>While Fresenius Medical Care AG &amp; Co. KGaA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 Fresenius Medical Care AG &amp; Co. KGaA 目前在分析師中被評為減持評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Given Consensus Rating of "Reduce" by Analysts

Market Beat

Fresenius Medical Care

花旗

Fresenius Medical Care AG & Co. KGaA（NYSE:FMS）被分析師一致給予 “減持” 評級